ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

3.08
Delayed Data
As of 4:00pm ET
 -0.06 / -1.91%
Today’s Change
2.92
Today|||52-Week Range
6.67
-25.60%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for ZIOPHARM Oncology Inc have a median target of 5.50, with a high estimate of 9.25 and a low estimate of 5.00. The median estimate represents a +78.57% increase from the last price of 3.08.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in ZIOPHARM Oncology Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$1.5M
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.22%
 
 
 
 
 
 
Growthannually -0.63%
 
 
 
 
 
 

Sales

Growthquarterly 928.65%
 
 
 
 
 
 
Growthannually -37.75%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.